These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7038690)

  • 1. Determinants of the selective toxicity of alloxan to the pancreatic B cell.
    Malaisse WJ; Malaisse-Lagae F; Sener A; Pipeleers DG
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):927-30. PubMed ID: 7038690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloxan toxicity to the pancreatic B-cell. A new hypothesis.
    Malaisse WJ
    Biochem Pharmacol; 1982 Nov; 31(22):3527-34. PubMed ID: 6758791
    [No Abstract]   [Full Text] [Related]  

  • 3. Human islets in mixed islet grafts protect mouse pancreatic beta-cells from alloxan toxicity.
    Tyrberg B; Eizirik DL; Marklund SL; Olejnicka B; Madsen OD; Andersson A
    Pharmacol Toxicol; 1999 Dec; 85(6):269-75. PubMed ID: 10628902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloxan in vivo does not only exert deleterious effects on pancreatic B cells.
    Szkudelski T; Kandulska K; Okulicz M
    Physiol Res; 1998; 47(5):343-6. PubMed ID: 10052602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between triketone structure, generation of reactive oxygen species, and selective toxicity of the diabetogenic agent alloxan.
    Elsner M; Gurgul-Convey E; Lenzen S
    Antioxid Redox Signal; 2008 Apr; 10(4):691-9. PubMed ID: 18177230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K; English D; Slonim AE; Burr IM
    Diabetes; 1984 Feb; 33(2):160-3. PubMed ID: 6229439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diethyldithiocarbamate, but not disulfiram, inhibits alloxan-induced dye accumulation of isolated mouse islet beta-cells.
    Norlund L; Grankvist K; Hansson HA; Norlund R
    Med Biol; 1986; 64(1):37-41. PubMed ID: 3014237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan.
    Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S
    Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro.
    Devi MM; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2004 Nov; 71(5):309-18. PubMed ID: 15380818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylurea: a radical scavenger that protects isolated pancreatic islets from the effects of alloxan and dihydroxyfumarate exposure.
    Fischer LJ; Hamburger SA
    Life Sci; 1980 Apr; 26(17):1405-9. PubMed ID: 6991844
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells.
    Elsner M; Gurgul-Convey E; Lenzen S
    Free Radic Biol Med; 2006 Sep; 41(5):825-34. PubMed ID: 16895803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective uptake of alloxan by pancreatic B-cells.
    Gorus FK; Malaisse WJ; Pipeleers DG
    Biochem J; 1982 Nov; 208(2):513-5. PubMed ID: 6760861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.
    Grankvist K; Marklund SL; Täljedal IB
    Biochem J; 1981 Nov; 199(2):393-8. PubMed ID: 7041886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of probucol on alloxan diabetes in rats.
    Matsushita M; Yoshino G; Iwai M; Matsuba K; Morita M; Iwatani I; Yoshida M; Kazumi T; Baba S
    Diabetes Res Clin Pract; 1989 Nov; 7(4):313-6. PubMed ID: 2693032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan.
    Tyrberg B; Andersson A; Borg LA
    Gen Comp Endocrinol; 2001 Jun; 122(3):238-51. PubMed ID: 11356036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetogenic action of alloxan-like compounds: cytotoxic effects of 5-hydroxy-pseudouric acid and dehydrouramil hydrate hydrochloride on rat pancreatic beta cells.
    Dominis M; Rocic S; Ashcroft SJ; Rocic B; Poje M
    Diabetologia; 1984 Sep; 27(3):403-6. PubMed ID: 6389244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effects of alloxan treatment in vitro on monolayer cultures of neonatal rat pancreas.
    Gorray KC; Baskin DG; Fujimoto WY
    Am J Physiol; 1983 Oct; 245(4):E417-23. PubMed ID: 6353938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.